Abstract

von Willebrand Factor (VWF) is an ultralong, concatameric, and adhesive glycoprotein. On short time scales, adhesiveness for platelets is activated by elongation of VWF by altered hydrodynamics at sites of hemostasis. Over longer time scales, the length of VWF is regulated by ADAMTS13 (a disintegrin and metalloprotease with a thrombospondin type 1 motif, member 13), cleavage by which in the VWF A2 domain is dependent on elongational force. Patients with von Willebrand disease type 2A present with increased bleeding due to mutations within the VWF A2 domain that enhance cleavage. We tested using temperature and force the hypothesis that von Willebrand disease mutations disrupt A2 force sensing by destabilizing the folded state. Mutations R1597W, M1528V, and E1638K reduced A2 thermal stability by 10-18 °C. M1528V and E1638K showed a marked further decrease in stability upon calcium removal. In contrast, R1597W, which resides within the A2 calcium-binding loop, exhibited similar stability in the presence and absence of calcium. Using single molecule optical tweezers and R1597W, we measured the force dependence of unfolding and refolding kinetics. In the presence of calcium, the R1597W mutation slowed the rate of refolding but had no effect on unfolding. The three mutations highlight the calcium-binding loop (R1597W), the hydrophobic core around the vicinal disulfide (M1528V), and hydrogen bonds to the α4-less loop (E1638K), as structural features critically important to the function of A2 as a force sensor in regulating thrombogenic activity in the vasculature.

Highlights

  • von Willebrand disease (VWD) mutations in the A2 domain increase cleavage by ADAMTS13

  • The length of von Willebrand Factor (VWF) is regulated by ADAMTS13, cleavage by which in the VWF A2 domain is dependent on elongational force

  • The results demonstrate the impact of VWD 2A mutations on A2 stability and provide insight into structural features regulating A2 unfolding and refolding dynamics that dictate ADAMTS13 cleavage

Read more

Summary

Background

VWD mutations in the A2 domain increase cleavage by ADAMTS13. Results: Three VWD mutations decreased thermal stability and altered single molecule force resistance. Patients with von Willebrand disease type 2A present with increased bleeding due to mutations within the VWF A2 domain that enhance cleavage. At the junction between winding 1 and winding 2, A2 features a unique calcium-binding site demonstrated to protect VWF against ADAMTS13 cleavage [6, 7] and enhance refolding [8]. We seek to understand the impact of VWD type 2A mutations on A2 conformational stability, and in particular, the dynamics of unfolding and refolding underlying enhanced cleavage of A2. The results demonstrate the impact of VWD 2A mutations on A2 stability and provide insight into structural features regulating A2 unfolding and refolding dynamics that dictate ADAMTS13 cleavage

EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call